2026 NPPES data Hematology & Oncology Physician NPI 1669444071 MD
Verify on CMS →

KOSTANDINOS SIDERAS, MD

Hematology & Oncology Physician in JACKSONVILLE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
272
Medicare Part D claims · 80 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.2008/100
▼ 7 pts below national avg 83.1 · [object Object]
Industry payments
$458.43
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KOSTANDINOS SIDERAS, MD reported a CMS MIPS final score of 76.2008/100 — below the 83.1 national average — and filed 272 Medicare Part D claims in 2023.

76.2008/100
MIPS score · -7 vs avg
272
Part D claims, 2023
85%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KOSTANDINOS SIDERAS, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

76 21st percentile higher than 21% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

KOSTANDINOS SIDERAS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KOSTANDINOS SIDERAS, MD?

Below national average

NPI registry status

Active

Issued 02/02/2006

NPI 1669444071

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

272 68% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

76.2008/100 6.899199999999993% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Hematology & Oncology Physician compares to other specialties among Florida providers

Florida providers

Hematology & Oncology Physician share within Florida

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Florida

Medicare quality performance — MIPS

KOSTANDINOS SIDERAS, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
76.2008/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 76.2008/100 vs national avg 83.1

0%100%National avg83%76.2%
MIPS final score (Hematology & Oncology Physician) — 76.2008/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KOSTANDINOS SIDERAS, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 4500 SAN PABLO RD S, JACKSONVILLE, FL, 32224, with a listed phone of (904) 953-2000. NPI 1669444071 was issued on 02/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SIDERAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 272 prescription claims written by this provider, covering 80 Medicare beneficiaries and totaling roughly $474K in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 4.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.2008/100 for the 2023 performance year (Quality 69.3395, Cost 51.3298), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4500 SAN PABLO RD S
JACKSONVILLE, FL 32224

Provider Details

NPI 1669444071
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 02/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.2008
Final Score
Avg: 83.1
69.3395
Quality
51.3298
Cost
100
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KOSTANDINOS SIDERAS, MD. Source: openpaymentsdata.cms.gov.

Total received

$458

Largest payer

BeiGene USA, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to KOSTANDINOS SIDERAS, MD. To verify KOSTANDINOS SIDERAS, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KOSTANDINOS SIDERAS, MD — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 272 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

272
Total Claims
$474K
Total Drug Cost
80
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
589
Total Day Supply
16,737
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$466K
Generic Drug Cost
$8K
Opioid Claims
13 (4.8% rate)

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
1.74

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KOSTANDINOS SIDERAS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
104
Anastrozole
34
Exemestane
14
Prochlorperazine Maleate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How KOSTANDINOS SIDERAS, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

KOSTANDINOS SIDERAS, MD's 272 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as SIDERAS.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KOSTANDINOS SIDERAS, MD's specialty?
KOSTANDINOS SIDERAS, MD specializes in Hematology & Oncology Physician and practices in JACKSONVILLE, Florida. Credentials: MD.
How much does KOSTANDINOS SIDERAS, MD prescribe under Medicare Part D?
In 2023, KOSTANDINOS SIDERAS, MD wrote 272 Medicare Part D claims totaling $474K in drug costs for 80 beneficiaries.
What is KOSTANDINOS SIDERAS, MD's Medicare quality score?
KOSTANDINOS SIDERAS, MD has a CMS MIPS Final Score of 76.2008/100 (Quality: 69.3395, Cost: 51.3298). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KOSTANDINOS SIDERAS, MD located?
KOSTANDINOS SIDERAS, MD is located at 4500 SAN PABLO RD S, JACKSONVILLE, FL, 32224. Phone: (904) 953-2000.
What is KOSTANDINOS SIDERAS, MD's NPI number?
KOSTANDINOS SIDERAS, MD's National Provider Identifier (NPI) is 1669444071, issued on 02/02/2006.
Does KOSTANDINOS SIDERAS, MD prescribe more brand-name or generic drugs?
KOSTANDINOS SIDERAS, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $466K in brand drug costs.
Does KOSTANDINOS SIDERAS, MD prescribe opioids?
Yes, KOSTANDINOS SIDERAS, MD had 13 opioid claims in 2023 with an opioid prescribing rate of 4.8%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does KOSTANDINOS SIDERAS, MD prescribe most often?
Based on 2023 Medicare Part D data, KOSTANDINOS SIDERAS, MD's most frequently prescribed drugs include Letrozole, Anastrozole, Exemestane. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KOSTANDINOS SIDERAS, MD accept Medicare?
KOSTANDINOS SIDERAS, MD appears in CMS Medicare data with 272 Part D claims and 80 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KOSTANDINOS SIDERAS, MD's credentials?
KOSTANDINOS SIDERAS, MD's NPI is 1669444071 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology